Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...
The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
Everyday Health on MSN6d
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 YearsThis antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
Verywell Health on MSN1d
A New FDA-Approved Antibiotic May Help Women With Recurring UTIsIf you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
A rare syndrome linked to purple urine reveals surprising insights into bacterial colonisation, metabolism, and risks for ...
The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the treatment of uncomplicated urinary tract infections (UTIs) in women aged ...
The minimum investment in UTI Small Cap Fund Regular Growth is Rs ... Multi Commodity Exchange Of Ind, Blue Star & Avanti Feeds. The major sectors where the fund is invested are Chemical ...
A northeast Portland neighborhood is grappling with a mystery man who leaves bottles of urine in their recycling bins, dropping the containers off in the middle of the night.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback